Illumina Inc (NASDAQ:ILMN)

408.63
Delayed Data
As of Apr 22
 +5.09 / +1.26%
Today’s Change
260.42
Today|||52-Week Range
555.77
+10.44%
Year-to-Date
Riverbridge Partners Llc Buys Grand Canyon Education Inc, 2U Inc, Amedisys Inc, Sells Proto ...
Apr 21 / GuruFocus News - Paid Partner Content
The Big Questions for Illumina After Its Q1 Sneak Peek and 2021 Guidance
Apr 14 / MotleyFool.com - Paid Partner Content
Illumina (ILMN) to Report Q1 Earnings: What's in the Offing?
Apr 21 / Zacks.com - Paid Partner Content
Alexandria Real Estate Equities Is My Favorite Office REIT
Apr 14 / MotleyFool.com - Paid Partner Content
3 Biden Healthcare Stocks to Watch
Apr 17 / MotleyFool.com - Paid Partner Content
Can Illumina (ILMN) Keep the Earnings Surprise Streak Alive?
Apr 12 / Zacks.com - Paid Partner Content
Is Illumina Still a Buy Without the GRAIL Acquisition?
Apr 15 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close403.33
Today’s open402.02
Day’s range402.02 - 411.43
Volume678,885
Average volume (3 months)1,121,805
Market cap$58.2B
Data as of 3:59pm ET, 04/22/2021

Growth & Valuation

Earnings growth (last year)-34.53%
Earnings growth (this year)+23.55%
Earnings growth (next 5 years)+12.00%
Revenue growth (last year)-8.58%
P/E ratio91.8
Price/Sales16.91
Price/Book12.41

Competitors

 Today’s
change
Today’s
% change
MRNAModerna Inc-1.40-0.83%
BIIBBiogen-10.85-4.02%
GILDGilead Sciences-1.15-1.72%
EXASExact Sciences Corp+1.22+0.95%
Data as of 6:13pm ET, 04/22/2021

Financials

Next reporting dateApril 28, 2021
EPS forecast (this quarter)$1.39
Annual revenue (last year)$3.2B
Annual profit (last year)$656.0M
Net profit margin20.25%

Profile

Sector
Health Technology
Industry
Biotechnology
No executives to display
Corporate headquarters
San Diego, California

Forecasts